Tobacco smoke-related health effects induced by 1,3-butadiene and strategies for risk reduction

Toxicological Sciences

Volumn 136, Issue 2, 2013, Pages 566-580

  Soeteman Hernández, Lya G ^a   Bos, Peter M J ^a   Talhout, Reinskje ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

1,3 butadiene; Mandated lowering; Margin of exposure; Risk reduction strategies; Smoke components

Indexed keywords

1,3 BUTADIENE; BUTADIENE DIEPOXIDE; CARBON; CIGARETTE SMOKE; NICOTINE; POLYMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATROPHY; BREAST TUMOR; CANCER RISK; CARCINOGENICITY; CONTROLLED STUDY; DOSE RESPONSE; ENVIRONMENTAL EXPOSURE; FEMALE; FOLLOW UP; HEALTH HAZARD; HUMAN; LEUKEMIA; LUNG ADENOCARCINOMA; LUNG CANCER; MALE; MIXED TUMOR; MOUSE; NONHUMAN; OCCUPATIONAL EXPOSURE; OVARY ATROPHY; OVARY DISEASE; RAT; RISK REDUCTION; SCIENTIFIC LITERATURE; SMOKING; WORLD HEALTH ORGANIZATION;

1,3-BUTADIENE; MANDATED LOWERING; MARGIN OF EXPOSURE.; RISK REDUCTION STRATEGIES; SMOKE COMPONENTS;

BUTADIENES; HUMANS; NEOPLASMS; RISK REDUCTION BEHAVIOR; SMOKE; TOBACCO;

EID: 84890395453     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kft194     Document Type: Article

References (85)

1. Adam, T., Mitschke, S., Streibel, T., Baker, R. R., and Zimmermann, R. (2006). Puff-by-puffresolved characterisation of cigarette mainstream smoke by single photon ionisation (SPI)-time-of-flight mass spectrometry (TOFMS): Comparison of the 2R4F research cigarette and pure Burley, Virginia, Oriental and Maryland tobacco cigarettes. Anal. Chim. Acta 572, 219-229.
2. Anderson, D., Hughes, J. A., Edwards, A. J., and Brinkworth, M. H. (1998). A comparison of male-mediated effects in rats and mice exposed to 1,3-butadiene. Mutat. Res. 397, 77-84.
3. ATSDR (1992). Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for 1,3-Butadiene. Public Health Service, U.S. Department of Health and Human Services, Atlanta, GA.
4. ATSDR (2012). Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for 1,3-Butadiene. Public Health Service, U.S. Department of Health and Human Services, Atlanta, GA. Available at: http://www.atsdr.cdc.gov/toxprofiles/tp28.pdf.
5. Baker, R. R., Coburn, S., Liu, C., and Tetteh, J. (2005). Pyrolysis of saccharide tobacco ingredients: A TGA-FTIR investigation. J. Anal. Appl. Pyrolysis 74, 171-180.
6. Bevan, C., Stadler, J. C., Elliott, G. S., Frame, S. R., Baldwin, J. K., Leung, H. W., Moran, E., and Panepinto, A. S. (1996). Subchronic toxicity of 4-vinylcyclohexene in rats and mice by inhalation exposure. Fundam. Appl. Toxicol. 32, 1-10.
7. Bos, P. M. J., Hernandez, L. G., Mennes, W. C., Kienhuis, A. S., and Talhout, R. (2012). Risk Assessment of Tobacco Additives and Smoke Components. RIVM letter rapport 340031001/2012. Available at: http://www.rivm.nl/en/Library/Scientific/Reports/2012/oktober/Risk_assessment_of_tobacco_ additives_and_smoke_components_a_method_proposal.
8. Boysen, G., and Hecht, S. S. (2003). Analysis of DNA and protein adducts of benzo[a]pyrene in human tissues using structure-specific methods. Mutat. Res. 543, 17-30.
9. Brunnemann, K. D., Kagan, M. R., Cox, J. E., and Hoffmann, D. (1990). Analysis of 1,3-butadiene and other selected gas-phase components in cigarette mainstream and sidestream smoke by gas chromatography-mass selective detection. Carcinogenesis 11, 1863-1868.
10. Burns, D. M., Dybing, E., Gray, N., Hecht, S., Anderson, C., Sanner, T., O'Connor, R., Djordjevic, M., Dresler, C., Hainaut, P., et al. (2008). Mandated lowering of toxicants in cigarette smoke: A description of the World Health Organization TobReg proposal. Tob. Control 17, 132-141.
11. CARB (1992). California Air Resources Board. Proposed identification of 1,3-butadiene as a Toxic Air Contaminant. Part A. Exposure Assessment. Stationary Source Division, Sacramento, CA.
12. CEPA (2000). Canadian Environmental Protection Act, 1999, Priority Substannces List Assessment Report for 1,3-Butadiene. Available at: http://www.hc-sc.gc.ca/ewh-semt/alt_formats/hecs-sesc/pdf/pubs/contaminants/psl2 lsp2/1_3_butadiene/1_3_butadiene-eng.pdf.
13. Counts, M. E., Morton, M. J., Laffoon, S. W., Cox, R. H., and Lipowicz, P. J. (2005). Smoke composition and predicting relationships for international commercial cigarettes smoked with three machine-smoking conditions. Regul. Toxicol. Pharmacol. 41, 185-227.
14. Csanády, G. A., Guengerich, F. P., and Bond, J. A. (1992). Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice. Carcinogenesis 13, 1143-1153.
15. Cunningham, F. H., Fiebelkorn, S., Johnson, M., and Meredith, C. (2011). A novel application of the Margin of Exposure approach: Segregation of tobacco smoke toxicants. Food Chem. Toxicol. 49, 2921-2933.
16. Dahl, A. R., Bechtold, W. E., Bond, J. A., Henderson, R. F., Mauderly, J. L., Muggenburg, B. A., Sun, J. D., and Birnbaum, L. S. (1990). Species differences in the metabolism and disposition of inhaled 1,3-butadiene and isoprene. Environ. Health Perspect. 86, 65-69.
17. Delzell, E., Macaluso, M., Sathiakumar, N., and Matthews, R. (2001). Leukemia and exposure to 1,3-butadiene, styrene and dimethyldithiocarbamate among workers in the synthetic rubber industry. Chem. Biol. Interact. 135-136, 515-534.
18. Delzell, E., Sathiakumar, N., Hovinga, M., Macaluso, M., Julian, J., Larson, R., Cole, P., and Muir, D. C. (1996). A follow-up study of synthetic rubber workers. Toxicology 113, 182-189.
19. Delzell, E., Sathiakumar, M., Macaluso, M., Hovinga, M., Larson, R., Brone, F., Beall, C., Cole, P., Julian, J., and Muir, D. C. F. (1995). A follow-up study of synthetic rubber workers. Submitted to the International Institute of Synthetic Rubber Producers, University of Alabama at Birmingham. October 2, 1995.
20. DHHS (2010). U.S. Department of Health and Human Services (DHHS): How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease. A Report on the Surgeon General. Available at: http://www.surgeongeneral.gov/library/reports/tobaccosmoke/full_report.pdf.
21. Djordjevic, M. V., Stellman, S. D., and Zang, E. (2000). Doses of nicotine and lung carcinogens delivered to cigarette smokers. J. Natl. Cancer Inst. 92, 106-111.
22. Doerr, J. K., Hollis, E. A., and Sipes, I. G. (1996). Species difference in the ovarian toxicity of 1,3-butadiene epoxides in B6C3F1 mice and Sprague- Dawley rats. Toxicology 113, 128-136.
23. Dowsley, T. F., Reid, K., Petsikas, D., Ulreich, J. B., Fisher, R. L., and Forkert, P. G. (1999). Cytochrome P-450-dependent bioactivation of 1,1-dichloroethylene to a reactive epoxide in human lung and liver microsomes. J. Pharmacol. Exp. Ther. 289, 641-648.
24. ECB (2002). European Chemicals Bureau, Institute for Health and Consumer Protection: European Union Risk Assessment Report for 1,3-Butadiene. Available at: http://echa.europa.eu/documents/10162/6434698/orats_final_ rar_buta-1_3-diene_en.pdf.
25. EFSA (2005). European Food Safety Authority (EFSA) Opinion of the Scientific Committee on a request from EFSA related to a harmonised approach for risk assessment of substances which are both genotoxic and carcinogenic, (Request No. EFSA-Q-2004-020). Available at: http://www. efsa.europa.eu/en/efsajournal/doc/282.pdf. Accessed October 18, 2012.
26. EFSA (2012). European Food Safety Authority: Scientific Opinion on Exploring Options for Providing Advice About Possible Human Health Risks Based on the Concept of Threshold of Toxicological Concern (TTC). Available at: http://www.efsa.europa.eu/de/efsajournal/pub/2750.htm. Accessed February 10, 2013.
27. EMTOC (2012). Electronic Model Tobacco Control. Available at: www.tabakinfo. nl/emtoc. Accessed December 1, 2012.
28. EPA (1992). Environmental Protection Agency (EPA) Air Resources Board and Office of Environmental Health Hazard Assesment (OEHHA): Proposed Identification of 1,3-Butadiene as a Toxic Air Contaminant. Available at: http://oehha.ca.gov/air/toxic_contaminants/html/1,3-Butadiene.htm. Accessed June 5, 2012.
29. EPA (2002a). U.S. Environmental Protection Agency (EPA). Health Assessment for 1,3-butadiene. Office of Research and Development, Washington, DC. EPA/600/P-98/001F.
30. EPA (2002b). U.S. Environmental Protection Agency (EPA): Health Assessment of 1,3-Butadiene. Available at: http://www.epa.gov/iris/supdocs/butasup.pdf. Accessed June 25, 2012.
31. FCTC (2010). Conference of the Parties of the WHO Framework Convention on Tobacco Control (FCTC) (2010) Partial Guidelines for Implementation of Articles 9 and 10 of the WHO Framework Convention on Tobacco Control (Regulation of the Contents of Tobacco Products and Regulation of Tobacco Product Disclosures). FCTC/COP4(10). Available at: http://www.who.int/fctc/guidelines/Decisions9and10.pdf. Accessed May 10, 2012.
32. FCTC (2012). World Health Organization Framework Convention on Tobacco Control. Available at: http://www.who.int/fctc/en/. Accessed May 10, 2012.
33. Fearon, I. M., Acheampong, D. O., and Bishop, E. (2012). Modification of smoke toxicant yields alters the effects of cigarette smoke extracts on endothelial migration: An in vitro study using a cardiovascular disease model. Int. J. Toxicol. 31, 572-583.
34. Ferguson, R. N. (2000). Report on Filler Precursors of Selected Smoke Constituents, Consultant Evaluation, Phillip Morris, USA, Bates # 2082742847.
35. Forkert, P. G. (1995). CYP2E1 is preferentially expressed in Clara cells of murine lung: localization by in situ hybridization and immunohistochemical methods. Am J Respir Cell Mol Biol 12, 589-596.
36. Fowles, J., and Dybing, E. (2003). Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tob. Control 12, 424-430.
37. Gordon, S. M., Wallace, L. A., Brinkman, M. C., Callahan, P. J., and Kenny, D. V. (2002). Volatile organic compounds as breath biomarkers for active and passive smoking. Environ. Health Perspect. 110, 689-698.
38. Grant, R. L., Haney, J., Curry, A. L., and Honeycutt, M. (2010). A chronic reference value for 1,3-butadiene based on an updated noncancer toxicity assessment. J. Toxicol. Environ. Health. B. Crit. Rev. 13, 460-475.
39. Hackett, P. L., Sikov, M. R., Mast T. J., Brown, M. G., Buschbom, R. L., Clark, M. L., Decker, J. R., Evanoff, J. J., Rommereim, R. L., Rowe, S. E., and Westerberg, R. B. (1987). Inhalation developmental toxicology studies: teratology study of 1,3-butadiene in mice (final report). Richland, WA: Pacific Northwest Laboratory; PNL Report No. PNL-6412 UC-48; NIH Report No. NIH-401-ES-40131; 92 p. Prepared for NIEHS, NTP, under a Related Services Agreement with the U.S. Department of Energy under contract DE-AC06-76RLO-1830.
40. Hazelton-Laboratories-Europe (1981). Hazelton Laboratories Europe Ltd. The toxicity and carcinogencity of butadiene gas administered to rats by inhalation for aproximately 24 months. Final Report prepared by P.E. Owen (Report No. 2653-522/2).
41. Hernández, L. G., Slob, W., van Steeg, H., and van Benthem, J. (2011). Can carcinogenic potency be predicted from in vivo genotoxicity data?: A metaanalysis of historical data. Environ. Mol. Mutagen. 52, 518-528.
42. Hukkanen, J., Pelkonen, O., Hakkola, J., and Raunio, H. (2002). Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung. Crit. Rev. Toxicol. 32, 391-411.
43. IARC (2008). International Agency for Research on Cancer (IARC) Monographs on the Evaluation of Carcinogenic Risks to Humans, 1,3-Butadiene, Ethylene Oxide and Vinyl Halides (Vinyl Fluoride, Vinyl Chloride and Vinyl Bromide) 97, http://monographs.iarc.fr/ENG/Monographs/vol97/mono97.pdf. IRIS (2013). Integrated Risk Information System. Available at: http://www.epa. gov/iris/subst/0139.htm. Accessed May 30, 2012.
44. IRIS (2013). Integrated Risk Information System. Available at: http://www.epa. gov/iris/subst/0139.htm. Accessed May 30, 2012.
45. Kirman, C. R., Albertini, R. J., Sweeney, L. M., and Gargas, M. L. (2010). 1,3-Butadiene: I. Review of metabolism and the implications to human health risk assessment. Crit. Rev. Toxicol. 40(Suppl. 1), 1-11.
46. Kirman, C. R., and Grant, R. L. (2012). Quantitative human health risk assessment for 1,3-butadiene based upon ovarian effects in rodents. Regul. Toxicol. Pharmacol. 62, 371-384.
47. Kreiling, R., Laib, R. J., Filser, J. G., and Bolt, H. M. (1986). Species differences in butadiene metabolism between mice and rats evaluated by inhalation pharmacokinetics. Arch. Toxicol. 58, 235-238.
48. Leffingwell, J. C. (1999). Basic chemical constituents of tobacco leaf and differences among tobacco types. In Tobacco: Production, Chemistry and Technology (D. L. Davis and M. T. Nielsen, Eds.), pp. 265-284. Blackwell Sciences, Oxford, UK.
49. Löfroth, G., Burton, R. M., Forehand, L., Hammond, S. K., Seila, R. L., Zweidinger, R. B., and Lewtas, J. (1989). Characterization of environmental tobacco smoke. Environ. Sci. Technol. 23, 610.
50. Macaluso, M., Larson, R., Delzell, E., Sathiakumar, N., Hovinga, M., Julian, J., Muir, D., and Cole, P. (1996). Leukemia and cumulative exposure to butadiene, styrene and benzene among workers in the synthetic rubber industry. Toxicology 113, 190-202.
51. Marian, C., O'Connor, R. J., Djordjevic, M. V., Rees, V. W., Hatsukami, D. K., and Shields, P. G. (2009). Reconciling human smoking behavior and machine smoking patterns: Implications for understanding smoking behavior and the impact on laboratory studies. Cancer Epidemiol. Biomarkers Prev. 18, 3305-3320.
52. Matanoski, G., Elliott, E., Tao, X., Francis, M., Correa-Villasenor, A., and Santos-Burgoa, C. (1997). Lymphohematopoietic cancers and butadiene and styrene exposure in synthetic rubber manufacture. Ann. N. Y. Acad. Sci. 837, 157-169.
53. Matanoski, G. M., Santos-Burgoa, C., and Schwartz, L. (1990). Mortality of a cohort of workers in the styrene-butadiene polymer manufacturing industry (1943-1982). Environ. Health Perspect. 86, 107-117.
54. McAdam, K. G., Gregg, E. O., Bevan, M., Dittrich, D. J., Hemsley, S., Liu, C., and Proctor, C. J. (2012). Design and chemical evaluation of reduced machine-yield cigarettes. Regul. Toxicol. Pharmacol. 62, 138-150.
55. McAdam, K. G., Gregg, E. O., Liu, C., Dittrich, D. J., Duke, M. G., and Proctor, C. J. (2011). The use of a novel tobacco-substitute sheet and smoke dilution to reduce toxicant yields in cigarette smoke. Food Chem. Toxicol. 49, 1684-1696.
56. McMichael, A. J., Spirtas, R., Gamble, J. F., and Tousey, P. M. (1976). Mortality among rubber workers: Relationship to specific jobs. J. Occup. Med. 18, 178-185.
57. McMichael, A. J., Spirtas, R., and Kupper, L. L. (1974). An epidemiologic study of mortality within a cohort of rubber workers, 1964-72. J. Occup. Med. 16, 458-464.
58. NTP (1984). National Toxicology Program (NTP), U.S. Public Health Service, U.S. Department of Health and Human Services. (1984) Toxicology and Carcinogenesis Studies of 1,3-Butadiene (CAS No. 106-99-0) in B6C3F1 Mice (inhalation studies). NTP TR 288, NIH Pub. No. 84-2544. National Toxicology Program, Research Triangle Park, NC.
59. NTP (1993). National Toxicology Program (NTP), U.S. Public Health Service, U.S. Department of Health and Human Services. (1993) Toxicology and Carcinogenesis Studies of 1,3-Butadiene (CAS No. 106-99-0) in B6C3F1 Mice (inhalation studies). NTP TR 434. National Toxicology Program, Research Triangle Park, NC. Available at: http://ntp.niehs.nih.gov/.
60. Pacchierotti, F., Adler, I. D., Anderson, D., Brinkworth, M., Demopoulos, N. A., Lähdetie, J., Osterman-Golkar, S., Peltonen, K., Russo, A., Tates, A., et al. (1998). Genetic effects of 1,3-butadiene and associated risk for heritable damage. Mutat. Res. 397, 93-115. 579
61. Paschke, T., Scherer, G., and Heller, W. D. (2002). Effects of ingredients on cigarette smoke composition and biological activity: A literature overview. Contr. Tob. Res. 20, 107-244.
62. Paulussen, J. J. C., Mahieu, C. M., and Bos, P. M. J. (1998). TNO Report V98.390: Default values in occupational risk assessment, Project number 257307/480306.
63. Penn, A., and Snyder, C. A. (1996). 1,3 Butadiene, a vapor phase component of environmental tobacco smoke, accelerates arteriosclerotic plaque development. Circulation 93, 552-557.
64. Penn, A., and Snyder, C. A. (2007). 1,3-Butadiene exposure and cardiovascular disease. Mutat. Res. 621, 42-49.
65. RIVM (2013). National Institute for Public Health and the Environment (RIVM). Toevoegingentabaksproducten. Available at: http://www.rivm.nl/toevoegingentabaksproducten/products.html. Accessed February 18, 2013.
66. Roemer, E., Schorp, M. K., Piadé, J. J., Seeman, J. I., Leyden, D. E., and Haussmann, H. J. (2012). Scientific assessment of the use of sugars as cigarette tobacco ingredients: A review of published and other publicly available studies. Crit. Rev. Toxicol. 42, 244-278.
67. Sanders, E. B., Goldsmith, A. I., Seeman, J. I. (2002). A model that distinguishes the pyrolysis of D-glucose, D-fructose, and sucrose from that of cellulose. Application to the understanding of cigarette smoke formation. J. Anal. Appl. Pyrolysis 66, 29-50.
68. Sathiakumar, N., Brill, I., and Delzell, E. (2009). 1,3-Butadiene, styrene and lung cancer among synthetic rubber industry workers. J. Occup. Environ. Med. 51, 1326-1332.
69. Sathiakumar, N., and Delzell, E. (2007). A follow-up study of women in the synthetic rubber industry: Study methods. Chem. Biol. Interact. 166, 25-28.
70. Sathiakumar, N., and Delzell, E. (2009). A follow-up study of mortality among women in the North American synthetic rubber industry. J. Occup. Environ. Med. 51, 1314-1325.
71. Sathiakumar, N., Delzell, E., Hovinga, M., Macaluso, M., Julian, J. A., Larson, R., Cole, P., and Muir, D. C. (1998). Mortality from cancer and other causes of death among synthetic rubber workers. Occup. Environ. Med. 55, 230-235.
72. Scherer, G., Urban, M., Engl, J., Hagedorn, H. W., and Riedel, K. (2006). Influence of smoking charcoal filter tipped cigarettes on various biomarkers of exposure. Inhal. Toxicol. 18, 821-829.
73. Schmidt, U., and Loeser, E. (1985). Species differences in the formation of butadiene monoxide from 1,3-butadiene. Arch. Toxicol. 57, 222-225.
74. Shepperd, C. J., Eldridge, A., Camacho, O. M., McAdam, K., Proctor, C. J., and Meyer, I. (2013). Changes in levels of biomarkers of exposure observed in a controlled study of smokers switched from conventional to reduced toxicant prototype cigarettes. Regul. Toxicol. Pharmacol. 66, 147-162. doi:10.1016/j. yrtph.2013.02.007
75. Sielken, R. L., Jr, and Valdez-Flores, C. (2001). Dose-response implications of the University of Alabama study of lymphohematopoietic cancer among workers exposed to 1,3-butadiene and styrene in the synthetic rubber industry. Chem. Biol. Interact. 135-136, 637-651.
76. Sielken, R. L., Jr, Valdez-Flores, C., Gargas, M. L., Kirman, C. R., Teta, M. J., and Delzell, E. (2007). Cancer risk assessment for 1,3-butadiene: Doseresponse modeling from an epidemiological perspective. Chem. Biol. Interact. 166, 140-149.
77. Smith, C. J., Perfetti, T. A., Rumple, M. A., Rodgman, A., and Doolittle, D. J. (2000). "IARC group 2A Carcinogens" reported in cigarette mainstream smoke. Food Chem. Toxicol. 38, 371-383.
78. Stayner, L. T., Dankovic, D. A., Smith, R. J., Gilbert, S. J., and Bailer, A. J. (2000). Human cancer risk and exposure to 1,3-butadiene-a tale of mice and men. Scand. J. Work. Environ. Health 26, 322-330.
79. Swenberg, J. A., Bordeerat, N. K., Boysen, G., Carro, S., Georgieva, N. I., Nakamura, J., Troutman, J. M., Upton, P. B., Albertini, R. J., Vacek, P. M., et al. (2011). 1,3-Butadiene: Biomarkers and application to risk assessment. Chem. Biol. Interact. 192, 150-154.
80. Swenberg, J. A., Koc, H., Upton, P. B., Georguieva, N., Ranasinghe, A., Walker, V. E., and Henderson, R. (2001). Using DNA and hemoglobin adducts to improve the risk assessment of butadiene. Chem. Biol. Interact. 135-136, 387-403.
81. Talhout, R., Opperhuizen, A., and van Amsterdam, J. G. (2006). Sugars as tobacco ingredient: Effects on mainstream smoke composition. Food Chem. Toxicol. 44, 1789-1798.
82. Urban, M., Gilch, G., Schepers, G., van Miert, E., and Scherer, G. (2003). Determination of the major mercapturic acids of 1,3-butadiene in human and rat urine using liquid chromatography with tandem mass spectrometry. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 796, 131-140.
83. van Sittert, N. J., Megens, H. J., Watson, W. P., and Boogaard, P. J. (2000). Biomarkers of exposure to 1,3-butadiene as a basis for cancer risk assessment. Toxicol. Sci. 56, 189-202.
84. WHO (2008). World Health Organization Technical Report Series 951: WHO Study Group on Tobacco Product Regulation Report on the Scientific Basis of Tobacco Product Regulation. Available at: http://www. who.int/tobacco/global_interaction/tobreg/publications/tsr_951/en/index. html. Accessed January 20, 2013.
85. WHO (2012). World Health Organization (WHO) (Chronic Obstructive Pulmonary Disease (COPD) Fact Sheet No. 315). Available at: http://www. who.int/mediacentre/factsheets/fs315/en/. Accessed January 20, 2013. 580